IRIS
MUCCINI, CAMILLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 281
EU - Europa 274
AS - Asia 124
AF - Africa 9
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 697
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 278
SE - Svezia 106
IT - Italia 89
CN - Cina 55
SG - Singapore 45
RU - Federazione Russa 33
FI - Finlandia 24
DE - Germania 9
AU - Australia 7
IN - India 7
AE - Emirati Arabi Uniti 6
NG - Nigeria 5
CH - Svizzera 4
PH - Filippine 4
CA - Canada 3
HK - Hong Kong 3
MD - Moldavia 3
FR - Francia 2
IR - Iran 2
NL - Olanda 2
PK - Pakistan 2
TN - Tunisia 2
ZA - Sudafrica 2
AT - Austria 1
BE - Belgio 1
EC - Ecuador 1
EU - Europa 1
Totale 697
Salva come PNG Salva come JPEG
Città #
New York 49
Ashburn 43
Shanghai 43
Singapore 30
Boardman 29
Helsinki 23
Lawrence 22
Princeton 22
Moscow 20
Milan 14
Washington 9
Melbourne 6
Seattle 6
Sharjah 6
Dallas 5
Lagos 5
Rome 5
Vittoria 5
Boston 4
Monsummano Terme 4
Pune 4
Quezon City 4
Vauderens 4
Angera 3
Cambridge 3
Chisinau 3
Naples 3
Bibiana 2
Borås 2
Catania 2
Cormano 2
Florence 2
Genoa 2
Guangzhou 2
Guanzate 2
Kai Yi Wan 2
Lahore 2
Los Angeles 2
Montreal 2
Nicolosi 2
Padova 2
Pontedera 2
Segrate 2
Torre Del Greco 2
Verona 2
Viterbo 2
Amsterdam 1
Central 1
Chennai 1
Delhi 1
Durban 1
Faenza 1
Falkenstein 1
Ferrara 1
Gent 1
Grammichele 1
Lainate 1
Lappeenranta 1
Legnano 1
Marseille 1
Messina 1
Paliano 1
Paris 1
Pavia 1
Perugia 1
Pisa 1
Pretoria 1
Quito 1
Recco 1
San Sperate 1
Sydney 1
Venlo 1
Vienna 1
Totale 439
Salva come PNG Salva come JPEG
Nome #
Evaluation of HIV reservoir in specific populations: people with a multi-drug resistant virus or a viral coinfection 111
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 46
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 35
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 31
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 27
Brief Report: Association Between Low HIV-1 DNA and Western Blot Reactivity to HIV-1 Pol in Chronically Infected Individuals 26
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 26
Changes in homeostatic model assessment for insulin resistance (HOMA-IR) index in treated HIV-1 infected people on virological suppression who switched to a different antiretroviral regimen 25
Efficacy and Safety Profile of Fostemsavir for the Treatment of People with Human Immunodeficiency Virus-1 (HIV-1): Current Evidence and Place in Therapy 23
Serum IgG1 and IgG4 could contribute to partial control of viral rebound in chronically HIV-1-infected patients 22
Cerebrospinal fluid viral replication and burden of resistance in three HIV-1-infected people taking Ibalizumab with multiple drug class-wide resistance 21
Dynamics of HIV-1 POL antibodies after ART in chronic HIV-1 infection 21
Western blot in treated people with HIV-1 chronic infection: frequency of negative HIV-1 pol genes 21
Anti-HIV antibodies are representative of the latent reservoir but do not correlate with viral control in people with long-lasting virological suppression undergoing analytical treatment interruption (APACHE study) 21
Analytical treatment interruption in chronic HIV-1 infection: Time and magnitude of viral rebound in adults with 10 years of undetectable viral load and low HIV-DNA (APACHE study) 20
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study) 20
Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium 20
Retrospective study on the outcome of two-drug regimens based on dolutegravir plus one reverse transcriptase inhibitor in virologically-suppressed HIV-infected patients 19
SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 Pandemic 19
Homeostatic model assessment for insulin resistance index trajectories in HIV-infected patients treated with different first-line antiretroviral regimens 16
Meningococcus B Vaccination Effectiveness Against Neisseria gonorrhoeae Infection in People Living With HIV: A Case-Control Study 15
Treatment success of rescue regimens after dual therapy failure in people living with HIV in a real-life setting 15
Immune activation, inflammation and HIV DNA after 96 weeks of ATV/r monotherapy: A MODAt substudy 14
Exercise ECG for coronary artery disease screening in people living with HIV: The cordis STUDY 14
Achieving virological control in pan-resistant HIV-1 infection: A case series 13
Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium 13
Challenging management of a post-coronavirus disease 2019 invasive Aspergillus sinusitis in a person living with HIV 12
Residual viremia in HIV-infected patients who continue a two-drug or switch to a three-drug integrase strand transfer inhibitor based regimen 11
Association of high-risk sexual behaviours with sexually transmitted infections among men who have sex with men living with HIV 10
Incidence of dyslipidemia in people with HIV who are treated with integrase inhibitors versus other antiretroviral agents 10
Increasing incidence and prevalence of metabolic syndrome in people living with HIV during the COVID-19 pandemic 9
Risk of Cardiovascular Diseases or Mortality in People with Higher Values of HIV-1 DNA 9
A four-drug combination oral tablet of darunavir, cobicistat, emtricitabine, and tenofovir alafenamide for the treatment of HIV-1 infection in adults 9
Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIV 8
Should we expect weight changes in people with HIV and a reported weight gain only by switching antiretroviral therapy? 8
Association between low levels of HIV-1 DNA and HLA class I molecules in chronic HIV-1 infection 8
A case of breakthrough mpox infection in an individual non-responder to MVA-BN vaccination 8
Impact of predicted HLA class I immunopeptidome on viral reservoir in a cohort of people living with HIV in Italy 8
Integrase Strand Transfer Inhibitor Use and Cancer Incidence in a Large Cohort Setting 7
Subclinical atherosclerosis as detected by carotid ultrasound and associations with cardiac and HIV-specific risk factors; the Archi-Prevaleat project 7
Increasing trend of transmitted integrase inhibitor resistance in a cohort of antiretroviral therapy-naive people living with HIV 7
Totale 785
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.665
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.665
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202120 0 0 0 4 0 9 0 5 1 0 1 0
2021/202249 0 0 0 8 1 6 4 10 8 3 2 7
2022/2023202 52 44 11 3 8 18 25 22 5 2 6 6
2023/2024428 14 16 79 30 49 71 41 38 3 16 15 56
2024/202585 66 19 0 0 0 0 0 0 0 0 0 0
Totale 785